Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
Critical Limb Ischemia - Drug Pipeline Landscape, 2023
... occurs, which markedly reduces blood-flow. It results in severe pain and even skin ulcers or sores. Peripheral artery disease causes chronic limb-threatening ischemia. Other causes of limb ischemia include embolisms, trauma and compartment syndrome. The ... Read More
-
Restless Legs Syndrome - Drug Pipeline Landscape, 2023
... thought to be associated with a dysfunction in the brain's dopamine system. This system is responsible for regulating movement and is also involved in the feeling of pleasure and reward. RLS is thought to be ... Read More
-
Uterine Fibroids - Drug Pipeline Landscape, 2023
... causes of fibroids are unknown. Most fibroids happen in people of reproductive age. Possible causes include genetic changes, hormones, other growth factors and extracellular matrix. Uterine fibroids patients may have symptoms, including excessive or painful ... Read More
-
Global Infantile Spasms Therapeutics Market Growth (Status and Outlook) 2023-2029
... Syndrome is characterized by infantile spasms, developmental regression, and a specific pattern on electroencephalography (EEG) testing called hypsarrhythmia (chaotic brain waves). The onset of infantile spasms is usually in the first year of life, typically ... Read More
-
Insomnia - Drug Pipeline Landscape, 2023
... and medical conditions. Treatment for insomnia typically includes lifestyle changes, such as avoiding caffeine and establishing a regular sleep schedule, as well as cognitive behavioral therapy and, in some cases, medication. There are two types ... Read More
-
Allergic Rhinitis - Drug Pipeline Landscape, 2023
... symptoms. It is strongly linked to asthma and conjunctivitis. Allergic rhinitis occurs when body's immune system reacts to an irritant in the air. Seasonal and perennial allergies can result from many allergens, including dust mites, ... Read More
-
Acne Vulgaris - Drug Pipeline Landscape, 2023
... genetics, fluctuating hormone levels, stress, high humidity and using oily personal care products. Four main factors causing acne include excess oil (sebum) production, hair follicles clogged by oil and dead skin cells, bacteria and inflammation. ... Read More
-
Nonalcoholic Steatohepatitis (NASH) - Drug Pipeline Landscape, 2023
... to cirrhosis, liver failure, and death. The exact cause of NASH is unknown, but it is believed to be associated with obesity, insulin resistance, and diabetes. Treatment of NASH is focused on weight loss, exercise, ... Read More
-
Global Eosinophilic Esophagitis Drug Market Growth 2023-2029
... cell. Symptoms are swallowing difficulty, food impaction, vomiting, and heartburn. Eosinophilic esophagitis was first described in children but also occurs in adults. The condition is not well understood, but food allergy may play a significant ... Read More
-
Cystic Fibrosis - Drug Pipeline Landscape, 2023
... causes a thick, sticky buildup of mucus in the lungs, pancreas, and other organs. In the lungs, the mucus clogs the airways and traps bacteria leading to infections, extensive lung damage, and eventually, respiratory failure. ... Read More
-
Atopic Dermatitis - Drug Pipeline Landscape, 2023
... Eczema damages the skin barrier function that makes skin more sensitive and more prone to infection and dryness. Atopic dermatitis is caused by a combination of immune system activation, genetics, environmental triggers and stress. A ... Read More
-
Global Orphan Drugs Market Research Report 2022 - Market Size, Current Insights and Development Trends
... report focuses on the Orphan Drugs market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed ... Read More
-
Asthma & COPD Therapies Market Report 2023-2033
... industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Expansion into Emerging Markets to Offer ... Read More
-
Acute Coronary Syndrome - Drug Pipeline Landscape, 2023
... flow to the heart muscle, the heart muscle can become damaged. Acute coronary syndrome causes no cell death, the reduced blood flow changes how the heart works and is a sign of a high risk ... Read More
-
Traumatic Brain Injury (TBI) - Drug Pipeline Landscape, 2023
... head, the head suddenly and violently hitting an object or when an object pierces the skull and enters brain tissue. Traumatic brain injury is the leading cause of death and disability worldwide and, can be ... Read More
-
Ovarian Cancer - Drug Pipeline Landscape, 2023
... on the origination in cell types which are epithelial ovarian cancer, stromal tumor and germ cell tumor. The exact cause of Ovarian cancer is still unclear but the risk factors include family history of ovarian/breast ... Read More
-
Ulcerative Colitis - Drug Pipeline Landscape, 2023
... lining of the colon and rectum. There is no recognized etiology for ulcerative colitis. However, specialists think that immune system dysfunction, genetics, modifications to the usual gut flora, and environmental factors may all be at ... Read More
-
Liver Cirrhosis - Drug Pipeline Landscape, 2023
... known as fibrosis as a result of liver disease damage. Cirrhosis is caused by alcoholic liver disease, non-alcoholic steatohepatitis (NASH), heroin abuse, chronic hepatitis B, and chronic hepatitis C. Cirrhosis symptoms emerge slowly until liver ... Read More
-
Acute Spinal Cord Injury - Drug Pipeline Landscape, 2023
... equina. The injury may cause a contusion, a partial tear or a complete tear transection in the spinal cord. Causes of acute spinal cord injury are damage to the vertebrae, ligaments or disks of the ... Read More
-
VITRAKVI Market Drug Insight and Market Forecast − 2032
... of the VITRAKVI for pancreatic cancer in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study period 2019 –2032 is provided in this ... Read More
-
VP-102 Emerging Drug Insight and Market Forecast – 2032
... of the VP-102 for Common Warts in the 7MM, i.e., the United States, EU4 (Germany, France, Italy and Spain) and the United Kingdom, and Japan for the study period 2019–2032 is provided in this report ... Read More
-
EUCRISA Market Drug Insight and Market Forecast − 2032
... picture of the EUCRISA for atopic dermatitis in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan, for the study period 2019 –2032 is provided in ... Read More
-
Netherlands Diabetes Market, Size, Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis
... with no available cure. According to IDF Europe, there are more than 60 million diabetic people in the European Region; by 2045, this number will rise by 13%. In the Netherlands, the prevalence of diabetes ... Read More
-
Cystic Fibrosis Therapeutics Market, Size, Global Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Company Analysis
... ongoing genetic disease that affects the lungs and other body systems (Pancreas, Liver, and Kidney) and for which there is currently no cure. It mainly affects the digestive and respiratory systems in children and young ... Read More
-
Androgenetic Alopecia - Market Insight, Epidemiology And Market Forecast - 2032
... well as the market trends of androgenetic alopecia in the United States, EU4 (Germany, Spain, Italy, France) and the United Kingdom, and Japan. The androgenetic alopecia market report provides current treatment practices, emerging drugs, market ... Read More
Research Assistance
